Design and Synthesis of Isatin-Tagged Isoniazid Conjugates with Cogent Antituberculosis and Radical Quenching Competence: In-vitro and In-silico Evaluations.
Autor: | Gavadia R; Department of Chemistry, M. D. University, Rohtak, Haryana, 124001, India., Rasgania J; Department of Chemistry, M. D. University, Rohtak, Haryana, 124001, India., Sahu N; Department of Chemistry, M. D. University, Rohtak, Haryana, 124001, India., Varma-Basil M; Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, 110007, India., Chauhan V; Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, 110007, India.; Department of Microbiology, M. D. University, Rohtak, Haryana, 124001, India., Kumar S; Department of Microbiology, M. D. University, Rohtak, Haryana, 124001, India., Mor S; Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, 125001, India., Singh D; Department of Chemistry, M. D. University, Rohtak, Haryana, 124001, India., Jakhar K; Department of Chemistry, M. D. University, Rohtak, Haryana, 124001, India. |
---|---|
Jazyk: | angličtina |
Zdroj: | Chemistry & biodiversity [Chem Biodivers] 2024 Oct; Vol. 21 (10), pp. e202400765. Date of Electronic Publication: 2024 Sep 06. |
DOI: | 10.1002/cbdv.202400765 |
Abstrakt: | In pursuit of potential chemotherapeutic alternates to combat severe tuberculosis infections, novel heterocyclic templates derived from clinically approved anti-TB drug isoniazid and isatin have been synthesized that demonstrate potent inhibitory action against Mycobacterium tuberculosis, and compound 4i with nitrophenyl motif exhibited the highest anti-TB efficacy with a MIC value of 2.54 μM/ml. Notably, the same nitro analog 4i shows the best antioxidant efficacy among all the synthesized compounds with an IC (© 2024 Wiley-VHCA AG, Zurich, Switzerland.) |
Databáze: | MEDLINE |
Externí odkaz: |